Research Nester released a report titled “Esophageal Cancer Treatment Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global esophageal cancer treatment market in terms of market segmentation by treatment type, end-user and region.Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.The esophageal cancer treatment market is projected to grow with a moderate CAGR during the forecast period, i.e., 2021-2029 on account of increasing research associated with esophageal cancer treatment and the rising investment in the development of advanced therapies.
As per International Agency for Research on Cancer, in 2020, the assessed number of deaths from esophageal cancer globally were 544,076, which accounted for 5.5% of the total global cancer deaths.The market is segmented by treatment type into surgery, endoscopic therapy, chemotherapy, immunotherapy, radiotherapy, targeted therapy, and others.
Among these segments, the chemotherapy segment is anticipated to hold the largest share by the end of 2021 in the esophageal cancer treatment market as a result of the higher positive diagnosis rates of chemotherapy than other available treatments.
On the basis of end-user, the market is segmented into general medical & surgical hospitals, speciality hospitals, clinics, and others.Download Sample of This Strategic Report: https://www.researchnester.com/sample-request-3006On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the esophageal cancer treatment market in the Asia Pacific is projected to grow at the highest CAGR throughout the forecast period.
Currently, the market in North America holds the largest share.
This can be attributed to the presence of leading healthcare providers in the region, especially in the United States, who are extensively involved in the research and development for innovative esophageal cancer treatment procedures.Increasing Research Associated with Esophageal Cancer Treatment and Rising Investment in the Development of Advanced Therapies to Drive Market GrowthAccording to the American Cancer Society, in 2017, the estimated new cases and deaths from esophageal cancer in U.S. were 16,940 and 15,690 respectively.The progress in research relating to esophageal cancer treatment has led to the discovery of various novel treatment procedures and drugs.
